Active surveillance in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal or junctional cancer

1987, The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C, World J Surg, 11, 426, 10.1007/BF01655805

1989, Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients, Int J Radiat Oncol Biol Phys, 16, 325, 10.1016/0360-3016(89)90323-4

1992, Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer, World J Surg, 16, 1104, 10.1007/BF02067069

1992, Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial, Radiother Oncol, 24, 108, 10.1016/0167-8140(92)90287-5

1995, Chemotherapy and combined-modality therapy for esophageal cancer, Chest, 107, 224S, 10.1378/chest.107.6_Supplement.224S

1999, Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group, JAMA, 281, 1623

2009, Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer, J Clin Oncol, 27, 5062, 10.1200/JCO.2009.22.2083

2011, Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial, J Clin Oncol, 29, 1715, 10.1200/JCO.2010.33.0597

2011, Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis, Lancet Oncol, 12, 681, 10.1016/S1470-2045(11)70142-5

2012, Preoperative chemoradiotherapy for esophageal or junctional cancer, N Engl J Med, 366, 2074, 10.1056/NEJMoa1112088

2015, Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial, Lancet Oncol, 16, 1090, 10.1016/S1470-2045(15)00040-6

2006, Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer, N Engl J Med, 355, 11, 10.1056/NEJMoa055531

2016, Multimodality treatment for esophageal adenocaricnoma: multi-center propensity-score matched study, Ann Oncol, 24, 1165

2014, Neo-AEGIS: a randomized clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the esophagus and esophagogastric junction, J Clin Oncol, 32

2016, A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction, Ann Oncol, 27, 660, 10.1093/annonc/mdw010

2011, Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial, Eur J Cancer, 47, 354, 10.1016/j.ejca.2010.09.009

2009, Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction, J Clin Oncol, 27, 851, 10.1200/JCO.2008.17.0506

2016, Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial, J Clin Oncol, 34, 2721, 10.1200/JCO.2015.65.7692

2010, Systematic classification of morbidity and mortality after thoracic surgery, Ann Thorac Surg, 90, 936, 10.1016/j.athoracsur.2010.05.014

2003, Outcomes after esophagectomy: a ten-year prospective cohort, Ann Thorac Surg, 75, 217, 10.1016/S0003-4975(02)04368-0

2011, Long-term health-related quality of life for disease-free esophageal cancer patients, World J Surg, 35, 1853, 10.1007/s00268-011-1123-6

2008, Long-term health-related quality of life following surgery for oesophageal cancer, Br J Surg, 95, 1121, 10.1002/bjs.6293

2009, Predictors of postoperative quality of life after esophagectomy for cancer, J Clin Oncol, 27, 1963, 10.1200/JCO.2008.20.5864

2007, Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists, Ann Surg Oncol, 14, 1678, 10.1245/s10434-006-9333-0

2013, Complete clinical response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic oesophagus: is surgery always necessary?, J Gastrointest Surg, 17, 1375, 10.1007/s11605-013-2269-3

2013, Targeting therapy for esophageal cancer in patients aged 70 and over, J Geriatr Oncol, 4, 107, 10.1016/j.jgo.2012.12.006

2012, Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation, Oncology, 83, 300, 10.1159/000341353

2013, Propensity-based matching between esophagogastric cancer patients who had surgery and who declined surgery after preoperative chemoradiation, Oncology, 85, 95, 10.1159/000351999

2004, Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results, Ann Surg, 240, 711, 10.1097/01.sla.0000141194.27992.32

2016, Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis, Lancet Oncol, 17, 174, 10.1016/S1470-2045(15)00467-2

2011, Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer, J Clin Oncol, 29, 4633, 10.1200/JCO.2011.37.7176

2016, PET-CT surveillance versus neck dissection in advanced head and neck cancer, N Engl J Med, 374, 1444, 10.1056/NEJMoa1514493

2014, Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials, J Clin Oncol, 32, 385, 10.1200/JCO.2013.51.2186

2002, Metastasis: dissemination and growth of cancer cells in metastatic sites, Nat Rev Cancer, 2, 563, 10.1038/nrc865

2014, Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer, Oncology, 86, 336, 10.1159/000360703

2017, Surgery for cancer: a trigger for metastases, Cancer Res, 77, 1548, 10.1158/0008-5472.CAN-16-1536

2015, Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern, Dis Esophagus, 28, 453, 10.1111/dote.12215

2009, Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer, Ann Surg, 249, 764, 10.1097/SLA.0b013e3181a38e9e

2008, Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer, Ann Surg, 248, 902, 10.1097/SLA.0b013e31818f3afb

1996, Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma, J Clin Oncol, 14, 156, 10.1200/JCO.1996.14.1.156

2015, Clinical complete response to chemo-radiotherapy in esophageal carcinoma: is surgery still required?, Submitted for publication

2013, Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa, Ann Surg, 258, 678, 10.1097/SLA.0b013e3182a6191d

2004, Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer, Ann Thorac Surg, 78, 1152, 10.1016/j.athoracsur.2004.04.046

2007, Value of complete metabolic response by 18F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy, Eur J Cancer, 43, 1385, 10.1016/j.ejca.2007.04.001

2016, Can CT-PET and endoscopic assessment postneoadjuvant chemoradiotherapy predict residual disease in esophageal cancer?, Ann Surg, 264, 831, 10.1097/SLA.0000000000001902

2014, Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma, Br J Surg, 101, 1702, 10.1002/bjs.9670

2017, Impact on radiological and pathological response with neoadjuvant chemoradiation and its effect on survival in squamous cell carcinoma of thoracic esophagus, J Gastrointest Cancer, 48, 42, 10.1007/s12029-016-9870-0

2005, The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy, J Thorac Cardiovasc Surg, 129, 1232, 10.1016/j.jtcvs.2004.12.042

2011, The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma, Eur J Surg Oncol, 37, 774, 10.1016/j.ejso.2011.06.002

2010, Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase II study by the Swiss Group for Clinical Cancer Research (SAKK 75/02), Gastrointest Endosc, 71, 1114, 10.1016/j.gie.2009.12.015

2015, Accuracy of detecting residual disease after CROSS neoadjuvant chemoradiotherapy for esophageal cancer (preSANO Trial): rationale and protocol, JMIR Res Protoc, 4, e79, 10.2196/resprot.4320

2014, Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer, Ann Surg, 260, 807, 10.1097/SLA.0000000000000966

2012, Does the timing of esophagectomy after chemoradiation affect outcome?, Ann Thorac Surg, 93, 207, 10.1016/j.athoracsur.2011.05.021

2010, Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome?, Ann Surg, 252, 788, 10.1097/SLA.0b013e3181fc7f86

2016, Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma, Eur J Surg Oncol, 42, 1183, 10.1016/j.ejso.2016.03.033

2015, Salvage surgery after chemoradiotherapy in the management of esophageal cancer: is it a viable therapeutic option?, J Clin Oncol, 33, 3866, 10.1200/JCO.2014.59.9092

2014, Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis, Ann Surg Oncol, 21, 922, 10.1245/s10434-013-3364-0

2015, Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland, Radiat Oncol, 10, 116, 10.1186/s13014-015-0418-4

2016, Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy, Radiother Oncol, 120, 128, 10.1016/j.radonc.2016.05.009

2015, Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer, Radiother Oncol, 115, 163, 10.1016/j.radonc.2015.04.027